Area of research
Hepatology · Statistics and Probability
Research interest
Research interests include Hepatocellular Carcinoma Treatment and Prognosis, Statistical Methods in Clinical Trials, Liver Disease and Transplantation, and Liver Disease Diagnosis and Treatment.
Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of patients with de novo coronary artery lesions (REC-CAGEFREE I): an open-label, randomised, non-inferiority trial
Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study☆
Efficacy and Safety of Ginkgo Diterpene Lactone Meglumine in Acute Ischemic Stroke
Lenvatinib with or without Concurrent Drug-Eluting Beads Transarterial Chemoembolization in Patients with Unresectable, Advanced Hepatocellular Carcinoma: A Real-World, Multicenter, Retrospective Study
Optimal time point of response assessment for predicting survival is associated with tumor burden in hepatocellular carcinoma receiving repeated transarterial chemoembolization
[Reflections on supervision strategies of new Tibetan drug registration].
Efficacy, Safety, and Tolerability of Ansofaxine (LY03005) Extended-Release Tablet for Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding, Phase 2 Clinical Trial
Exploratory Analysis to Identify Candidates Benefitting from Combination Therapy of Transarterial Chemoembolization and Sorafenib for First-Line Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Observational Study
Validation and evaluation of clinical prediction systems for first and repeated transarterial chemoembolization in unresectable hepatocellular carcinoma: A Chinese multicenter retrospective study
Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: A multicentre observational study
A Randomized Multicenter Phase III Study of Single Administration of Mecapegfilgrastim (HHPG-19K), a Pegfilgrastim Biosimilar, for Prophylaxis of Chemotherapy-Induced Neutropenia in Patients With Advanced Non–Small-Cell Lung Cancer (NSCLC)
An Inactivated Enterovirus 71 Vaccine in Healthy Children
Multicenter randomized double-blind controlled phase III study of hhpg-19K as prophylactic therapy in patients with advanced non-small cell lung cancer (NSCLC) receiving myelosuppressive chemotherapy.
Ginsenoside‐Rd improves outcome of acute ischaemic stroke – a randomized, double‐blind, placebo‐controlled, multicenter trial